Harrow Inc (HROW)
17.95
+0.11
(+0.62%)
USD |
NASDAQ |
May 31, 16:00
18.09
+0.14
(+0.78%)
After-Hours: 20:00
Harrow Revenue (Quarterly): 34.59M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 34.59M |
| December 31, 2023 | 36.36M |
| September 30, 2023 | 34.26M |
| June 30, 2023 | 33.47M |
| March 31, 2023 | 26.10M |
| December 31, 2022 | 20.33M |
| September 30, 2022 | 22.82M |
| June 30, 2022 | 23.32M |
| March 31, 2022 | 22.12M |
| December 31, 2021 | 20.19M |
| September 30, 2021 | 18.71M |
| June 30, 2021 | 18.13M |
| March 31, 2021 | 15.44M |
| December 31, 2020 | 14.60M |
| September 30, 2020 | 14.40M |
| June 30, 2020 | 8.06M |
| March 31, 2020 | 11.82M |
| December 31, 2019 | 12.60M |
| September 30, 2019 | 12.76M |
| June 30, 2019 | 13.52M |
| March 31, 2019 | 12.29M |
| December 31, 2018 | 11.38M |
| September 30, 2018 | 10.74M |
| June 30, 2018 | 10.38M |
| March 31, 2018 | 8.865M |
| Date | Value |
|---|---|
| December 31, 2017 | 7.337M |
| September 30, 2017 | 6.483M |
| June 30, 2017 | 6.857M |
| March 31, 2017 | 6.097M |
| December 31, 2016 | 5.793M |
| September 30, 2016 | 4.861M |
| June 30, 2016 | 4.907M |
| March 31, 2016 | 4.381M |
| December 31, 2015 | 3.503M |
| September 30, 2015 | 2.683M |
| June 30, 2015 | 1.967M |
| March 31, 2015 | 1.563M |
| December 31, 2014 | 0.55M |
| September 30, 2014 | 0.441M |
| June 30, 2014 | 0.667M |
| March 31, 2014 | 0.002M |
| December 31, 2013 | 0.0025M |
| September 30, 2013 | 0.0025M |
| June 30, 2013 | 0.0025M |
| March 31, 2013 | 0.0025M |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | 0.10M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.06M
Minimum
Jun 2020
36.36M
Maximum
Dec 2023
20.68M
Average
19.45M
Median
Revenue (Quarterly) Benchmarks
| Durect Corp | 1.827M |
| Aquestive Therapeutics Inc | 12.05M |
| Cyclacel Pharmaceuticals Inc | 0.029M |
| Stereotaxis Inc | 6.88M |
| Cara Therapeutics Inc | 2.135M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.56M |
| Total Expenses (Quarterly) | 41.52M |
| EPS Diluted (Quarterly) | -0.38 |
| Enterprise Value | 742.93M |
| Gross Profit Margin (Quarterly) | 69.49% |
| Profit Margin (Quarterly) | -39.22% |
| Earnings Yield | -5.13% |
| Normalized Earnings Yield | -4.978 |